Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients

[1]  S. Yamashita,et al.  CD36 mediates long-chain fatty acid transport in human myocardium: Complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency , 1999, Molecular and Cellular Biochemistry.

[2]  S. Yamashita,et al.  Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism. , 2003, Diabetes care.

[3]  A. Bonen,et al.  Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. , 2002, The Journal of clinical investigation.

[4]  宮岡 宏治.  CD36 deficiency associated with insulin resistance , 2002 .

[5]  A. Glazier,et al.  Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism , 2002, Mammalian Genome.

[6]  H. Chiba,et al.  Metabolic Changes in Human CD36 Deficiency Displayed by Glucose Loading , 2001, Thrombosis and Haemostasis.

[7]  R. Silverstein,et al.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. , 2001, The Journal of clinical investigation.

[8]  T. Kurtz,et al.  Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial Hypertrophy* , 2001, The Journal of Biological Chemistry.

[9]  S. Yamashita,et al.  Localization of CD36 and scavenger receptor class A in human coronary arteries--a possible difference in the contribution of both receptors to plaque formation. , 2001, Atherosclerosis.

[10]  Y. Matsuzawa,et al.  Analyses of genetic abnormalities in type I CD36 deficiency in Japan: identification and cell biological characterization of two novel mutations that cause CD36 deficiency in man , 2001, Human Genetics.

[11]  T. Nakata,et al.  Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations. , 2001, Journal of lipid research.

[12]  K. Matsumoto,et al.  Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen. , 2001, Biochemical and biophysical research communications.

[13]  S. Yamashita,et al.  CD36 deficiency associated with insulin resistance , 2001, The Lancet.

[14]  T. Kurtz,et al.  Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats , 2001, Nature Genetics.

[15]  H. Chiba,et al.  Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol. , 2000, American journal of medical genetics.

[16]  K. Matsumoto,et al.  Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[17]  S. Yamashita,et al.  Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[19]  K. Matsumoto,et al.  Expression of macrophage (Mphi) scavenger receptor, CD36, in cultured human aortic smooth muscle cells in association with expression of peroxisome proliferator activated receptor-gamma, which regulates gain of Mphi-like phenotype in vitro, and its implication in atherogenesis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[20]  R. Silverstein,et al.  A Null Mutation in Murine CD36 Reveals an Important Role in Fatty Acid and Lipoprotein Metabolism* , 1999, The Journal of Biological Chemistry.

[21]  M. Bihoreau,et al.  Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance , 1999, Nature Genetics.

[22]  K. Matsumoto,et al.  CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[23]  James Scott,et al.  Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats , 1999, Nature Genetics.

[24]  K. Matsumoto,et al.  Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Evans,et al.  Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ , 1998, Cell.

[26]  K. Kawamura,et al.  Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? , 1997, Journal of molecular and cellular cardiology.

[27]  S. Yamashita,et al.  Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. , 1995, The Journal of clinical investigation.

[28]  P. Grimaldi,et al.  Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. , 1993, The Journal of biological chemistry.

[29]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[30]  Y. Matsuzawa,et al.  A Novel Polymorphism in Glycoprotein IV (Replacement of Proline-90 by Serine) Predominates in Subjects with Platelet GPIV Deficiency , 1993, Thrombosis and Haemostasis.

[31]  Y. Tomiyama,et al.  A platelet membrane glycoprotein (GP) deficiency in healthy blood donors: Naka- platelets lack detectable GPIV (CD36) , 1990 .

[32]  N. Tandon,et al.  Isolation and characterization of platelet glycoprotein IV (CD36). , 1989, The Journal of biological chemistry.